Table 1.
Liver transplant recipients with past or present HBV infection
| Characteristics | Group 1 (HBV immune) | Group 2 (HBV infected) | Group 3 (HBV fulminant) |
|---|---|---|---|
| N | 38 | 51 | 8 |
| Age (range) | 45.6 (23.2 to 56.8) | 46.6 (16 to 66.5) | 30.6 (21 to 51.1) |
| Men/Women | 25/13 | 46/5a | 4/4 |
| Patients with tumor (%) | 6/38 (15.8%) | 11/51 (21.6%) | 0/8 (0) |
| Duration of disease (range) | 7.6 yr (0.3 to 26) | 6.9 yr (0.5 to 22) | 3.3 wk (1 to 8) |
| Urgency status (old UNOS)b | 3.1 ± 1.3 | 3.4 ± 1.1 | 5.1 ± 1.0 |
| Gastrointestinal bleeding (%) | 12/38 (37%) | 12/51 (23%) | 0/8 (0) |
| Encephalopathy (%) (Stage 3) | 11/38 (29%) | 19/51 (37%) | 7/8 (87.5%) |
| Hepatorenal (%) (Cr > 3 mg/dl) | 3/38 (8%) | 4/51 (8%) | 3/8 (37.5%) |
| Total bilirubin (mg/dl) | 6.8 ± 9.1 | 7.9 ± 12.1 | 21.6 ± 9.1 |
| Serum albumin (gm/dl) | 2.8 ± 0.4 | 2.7 ± 0.5 | 2.9 ± 0.5 |
| Prothrombin time (sec) | 15.5 ± 2.1 | 16.0 ± 2.9 | 24.3 ± 6.6 |
| Creatinine (mg/dl) | 1.1 ± 0.5 | 1.2 ± 0.8 | 1.2 ± 0.8 |
Values are mean ± S.D. unless otherwise stipulated.
a
p < 0.05 compared with the other two groups.
b
UNOS = United Network for Organ Sharing.